骨质疏松症
医学
肾脏疾病
脆弱性
重症监护医学
尿毒症
风险因素
内科学
疾病
物理化学
化学
作者
Hanne Skou Jørgensen,Karel David,Syazrah Salam,Pieter Evenepoel
标识
DOI:10.1007/s00223-020-00786-0
摘要
Osteoporosis is a state of bone fragility with reduced skeletal resistance to trauma, and consequently increased risk of fracture. A wide range of conditions, including traditional risk factors, lifestyle choices, diseases and their treatments may contribute to bone fragility. It is therefore not surprising that the multi-morbid patient with chronic kidney disease (CKD) is at a particularly high risk. CKD is associated with reduced bone quantity, as well as impaired bone quality. Bone fragility in CKD is a composite of primary osteoporosis, accumulation of traditional and uremia-related risk factors, assaults brought on by systemic disease, and detrimental effects of drugs. Some risk factors are modifiable and represent potential targets for intervention. This review provides an overview of the heterogeneity of bone fragility in CKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI